
Nuwellis, Inc. Stock Plummets to New 52-Week Low of $3.54
2025-09-22 18:11:49Nuwellis, Inc., a microcap pharmaceutical company, recently hit a 52-week low, reflecting ongoing financial struggles. The company reported a 21.47% drop in net sales and a significant pre-tax loss. With limited long-term growth prospects and a negative EBIT to interest ratio, Nuwellis faces challenges in a volatile market.
Read MoreIs Nuwellis, Inc. technically bullish or bearish?
2025-09-20 19:21:04As of 1 August 2025, the technical trend for Nuwellis, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bullish, while the monthly MACD also indicates a mildly bullish stance. However, the weekly RSI is bearish, contrasting with the monthly RSI which is bullish. The Bollinger Bands and Dow Theory show bearish signals on both weekly and monthly time frames. Moving averages are bearish on a daily basis, and the KST is bearish weekly but mildly bullish monthly. Overall, the technical stance is mildly bullish but mixed, with key indicators showing weakness in the short term. In terms of performance, Nuwellis has significantly underperformed the S&P 500 across all periods, with a year-to-date return of -91.89% compared to the S&P 500's 12.22%....
Read More
Nuwellis, Inc. Stock Plummets to New 52-Week Low of $3.65
2025-09-19 13:00:49Nuwellis, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company reported a quarterly net sales figure of USD 1.73 million and a substantial pre-tax loss, indicating ongoing operational challenges and a weak financial position.
Read More





